Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-087461
Filing Date
2024-07-29
Accepted
2024-07-29 20:16:08
Documents
2
Period of Report
2024-07-23

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7385
2 EX-24.POA bbio-ex24_poa.htm EX-24.POA 8970
  Complete submission text file 0000950170-24-087461.txt   17874
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304
Business Address
Trimarchi Thomas (Reporting) CIK: 0002030813 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38959 | Film No.: 241154088